A portable negative air pressure apparatus for isolating a treatment subject to permit a selected treatment procedure to be performed by a treatment operator. The apparatus comprises an air source connected to a closed chamber for sealable disposition over the head, neck and upper thorax of the treatment subject with the chamber having air ports, in and out. The chamber has rigid clear sides and a plurality of sealed ports, with the ports including sealed armholes for access, and with sealed gloves connected to the sealed armholes. The chamber also has at least one instrument hatch to permit introduction into the chamber of instruments for carrying-out the selected treatment procedure.

The invention may be embodied as a patient isolation device. The patient isolation device may comprise a cover having a first lower surface having an interior edge and an exterior edge, a second lower surface having an interior edge and an exterior edge, an interior surface extending between the interior edges, and an exterior surface extending between the exterior edges. The interior surface may define a patient space within which a patient may be positioned. The exterior surface may be substantially parallel to the interior surface. One or more extensions may be configured to be disposed between a mattress of a hospital bed, each extending proximate a lower surface of the cover. At least a portion of the interior surface may be arc-shaped and configured to define a patient space within which a patient may be positioned.

The invention may be embodied as a patient isolation device. The patient isolation device may comprise a cover having a first lower surface having an interior edge and an exterior edge, a second lower surface having an interior edge and an exterior edge, an interior surface extending between the interior edges, and an exterior surface extending between the exterior edges. The interior surface may define a patient space within which a patient may be positioned. The exterior surface may be substantially parallel to the interior surface. One or more extensions may be configured to be disposed between a mattress of a hospital bed, each extending proximate a lower surface of the cover. At least a portion of the interior surface may be arc-shaped and configured to define a patient space within which a patient may be positioned.

A hydrogen supply apparatus includes: an air path having an inlet and an outlet; a fan that is disposed in the air path and produces a flow of air from the inlet to the outlet; a first pipe having an end that forms a first supply port through which to supply hydrogen gas to the air path; a flow control device that is attached to the first pipe and adjusts a flow rate of the hydrogen gas; and a hydrogen gas sensor, disposed downstream of the fan or the end in a direction of flow of the air that detects a concentration of the hydrogen gas in the air path, where the end is disposed between the fan and the outlet or between the fan and the inlet in the air path.

A hydrogen supply apparatus includes: an air path having an inlet and an outlet; a fan that is disposed in the air path and produces a flow of air from the inlet to the outlet; a first pipe having an end that forms a first supply port through which to supply hydrogen gas to the air path; a flow control device that is attached to the first pipe and adjusts a flow rate of the hydrogen gas; and a hydrogen gas sensor, disposed downstream of the fan or the end in a direction of flow of the air that detects a concentration of the hydrogen gas in the air path, where the end is disposed between the fan and the outlet or between the fan and the inlet in the air path.

A capsule pod sleeping chamber with a ceiling and walls adjacent to the ceiling sealing an interior space to prevent a mixture of air between the interior space and a communal space exterior to the portable enclosure. The capsule pod sleeping chamber has first duct to route supply air into the interior space from a first area that is separated from the communal space and a second duct to route exhaust air out from the interior space to a second area separated from the communal space. Lastly, the capsule pod sleeping chamber has a plurality of apertures located in at least one wall of the plurality of walls that include the first aperture opening into the first duct and the second aperture opening into the second duct.

A capsule pod sleeping chamber with a ceiling and walls adjacent to the ceiling sealing an interior space to prevent a mixture of air between the interior space and a communal space exterior to the portable enclosure. The capsule pod sleeping chamber has first duct to route supply air into the interior space from a first area that is separated from the communal space and a second duct to route exhaust air out from the interior space to a second area separated from the communal space. Lastly, the capsule pod sleeping chamber has a plurality of apertures located in at least one wall of the plurality of walls that include the first aperture opening into the first duct and the second aperture opening into the second duct.

Provided is a clean booth in an assembled state, including: a frame; a wall portion that is provided on the frame and forms an internal space; a first unit that is provided on the wall portion and includes a first fan that supplies air to the internal space via a first filter; and a second unit that is provided on the wall portion and includes a second fan that exhausts the air in the internal space.

Provided is a clean booth in an assembled state, including: a frame; a wall portion that is provided on the frame and forms an internal space; a first unit that is provided on the wall portion and includes a first fan that supplies air to the internal space via a first filter; and a second unit that is provided on the wall portion and includes a second fan that exhausts the air in the internal space.

Methods and apparatus for producing a treatment dose of engineered cells for individual patients at the point-of-care location. In some embodiments, a patient treatment system includes a mobile cell and gene processing station that provides individualized patient treatments at point-of-care locations. The cell and gene processing station may include a patient chamber configured to isolate a patient from an external environment, a first environment controller to adjust environmental parameters of the patient chamber, a processing chamber configured to isolate processing of patient cells from the external environment, a second environment controller to adjust environmental parameters of the processing chamber, a first apparatus configured to receive at least one blood sample from the patient, a second apparatus configured to process the blood sample, and a third apparatus configured to perform cell and gene engineering on the blood sample to create a treatment dose for the patient.